Knopp Biosciences: Knopp Biosciences LLC: Knopp Biosciences to Present Details of Positive Results From the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma at ATS 2021
Poster presentation will describe effects of dexpramipexole on blood absolute eosinophil count, lung function, and safety Knopp Biosciences LLC today announced it will present detailed results of ...
Read full article »
Knopp Biosciences is a drug discovery company that develops and commercializes medicines for the treatment of immunological and neurological diseases.
Read more